Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
forgeperformanceco.com
Samples
Passed
Failed
Trust score updated: May 28, 2026 · 100% pass rate
Composite score based on 22 COAs attributed to this vendor.
Mean HPLC purity across published COAs
Per-peptide coverage of identity / endotoxin / microbial / heavy-metals / net-content panels
Lab corroboration tier — confirmed via public verify portal (90), presumptive trusted lab (85), lab resolved but unverified (75), or no lab attribution (50)
| Date | Peptide | Test | Result | Purity | Lab | Notes |
|---|---|---|---|---|---|---|
| Apr 24, 2026 | SLU-PP-332 | Identity & safety panels | PASS | -- | Ethos Analytics | Lot 26103001 · Report 26EA0421-015 |
| Mar 27, 2026 | Tesamorelin | HPLC purity | PASS | 99.115% | Freedom Diagnostics | Lot Clear Red Cap · Report 2603270080 |
| Mar 27, 2026 | Tirzepatide | HPLC purity | PASS | 99.763% | Freedom Diagnostics |
We are continuously testing more products. Scores update with each new result.
Read our scoring methodology →Trust scores are computed from indexed Certificates of Analysis — vendor-published, and lab-confirmed where a lab copy verifies them — using a fixed, versioned methodology (v13). They are not based on independent blind-purchase testing, and no vendor can pay for placement or a higher score. How we score · How we make money
Inverse of CoaFlag count (lot collisions, hash collisions, etc.)
Composite of 22 COAs attributed to this vendor. Last recomputed 2026-05-28.
Non-fixed VoIP phone (-0.04), New domain (-0.06), Full identity on file (0.03), Lab-confirmed (0.02)
Sources: RDAP/WHOIS for domain data, Twilio Lookup for phone classification, Google Places for address verification. Crawl runs weekly. Signals are independent of vendor-supplied data.
| Lot Orange Cap · Report 2603270081 |
| Mar 23, 2026 | SS-31 | HPLC purity | PASS | 99.937% | Freedom Diagnostics | Lot Blue Top · Report 2603230072 |
| Mar 23, 2026 | MOTS-C | HPLC purity | PASS | 99.695% | Freedom Diagnostics | Lot Purple Top · Report 2603230073 |
| Feb 9, 2026 | BPC-157 | HPLC purity | PASS | 99.53% | BioRegen | Report 12131 |
| Jan 28, 2026 | TB-500 | HPLC purity | PASS | 99.63% | BioRegen | Report 12014 |
| Jan 7, 2026 | Tirzepatide | HPLC purity | PASS | 99.82% | BioRegen | Report 11783 |
| Dec 29, 2025 | Semax | HPLC purity | PASS | 98.664% | Freedom Diagnostics | Report 2512290070 |
| Dec 29, 2025 | GHK-Cu | HPLC purity | PASS | 99.888% | Freedom Diagnostics | Report 2512290072 |
| Dec 29, 2025 | Tesamorelin | HPLC purity | PASS | 99.457% | Freedom Diagnostics | Report 2512290071 |
| Dec 22, 2025 | Retatrutide | HPLC purity | PASS | 99.87% | BioRegen | Report 11635 |
| Dec 22, 2025 | Retatrutide | HPLC purity | PASS | 99.62% | BioRegen | Report 11634 |
| Dec 22, 2025 | Retatrutide | HPLC purity | PASS | 99.87% | BioRegen | Report 11635 |
| Dec 22, 2025 | Retatrutide | HPLC purity | PASS | 99.62% | BioRegen | Report 11634 |
| Jun 4, 2026 | MOTS-C | HPLC purity | PASS | 99.571% | Freedom Diagnostics | Report 2512290069 |
| Jun 4, 2026 | Ipamorelin/CJC-1295 | HPLC purity | PASS | 99.903% | Freedom Diagnostics | Report 2512290068 |
| Jun 4, 2026 | NAD+ | HPLC purity | PASS | 99.934% | Freedom Diagnostics | Report 2602030359 |
| Jun 4, 2026 | TB-500 | HPLC purity | PASS | 99.535% | Freedom Diagnostics | Report 2602030025 |
| Jun 4, 2026 | BPC-157 | HPLC purity | PASS | 99.28% | Freedom Diagnostics | Lot Clear Blue Cap · Report 2604160083 |
| Jun 4, 2026 | HCG | Identity & safety panels | PASS | -- | Vanguard Laboratory | Lot Orange Cap · Report V260311-21 001 |
| Jun 4, 2026 | GHK-Cu/KPV/BPC-157/Thymosin Beta-4 | HPLC purity | PASS | 99.743% | Freedom Diagnostics | Report 2602050149 |